Cytotoxicity grading assessment is a fundamental in vitro biological evaluation required for medical devices under ISO 10993-5 and GB/T 16886.5, determining whether device materials or their extracts cause cell death, morphological damage, or growth inhibition in cultured mammalian cells. This technical guide explains the 0–4 grading system, sample preparation requirements, test methodologies, and acceptance criteria used by accredited third-party laboratories to support global regulatory submissions.
Technical Overview
Cytotoxicity grading assessment is the first and most widely performed test in the biological evaluation program of medical devices, as defined by ISO 10993-1 (Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process). It measures whether a device, its constituent materials, or substances extracted from the device exert a toxic effect on cultured mammalian cells. Because the test is rapid, sensitive, and cost-effective, it serves as the primary screening endpoint for any device with patient-contacting surfaces, regardless of contact duration or contact category.
The core standard governing the test methodology is ISO 10993-5 (Tests for in vitro cytotoxicity), with sample preparation governed by ISO 10993-12 (Sample preparation and reference materials). The Chinese national equivalent, GB/T 16886.5, is technically aligned with ISO 10993-5 and is the acceptance basis for device registration with Chinese regulatory authorities. Additional recognized methods include USP <87> for in vitro biological reactivity and ASTM F813 and ASTM F895 for direct contact and agar diffusion testing, respectively.
The test principle is straightforward: cultured cells (most commonly L929 mouse fibroblasts) are exposed to the test article or to a liquid extract of the article. After a defined incubation period, cellular responses are evaluated either qualitatively by microscopic morphological grading on a 0–4 scale, or quantitatively by measuring cell viability using colorimetric bioassays such as MTT. The resulting grade, together with the percentage of cell viability relative to untreated controls, determines whether the device meets cytotoxicity acceptance criteria.
Testing Samples
Practically every category of medical device and biomaterial can be evaluated. Sample form, geometry, and intended use determine whether the article is tested directly, indirectly, or as an extract. Representative sample categories include the following.
Polymeric Devices and Elastomer Components
Intravenous catheters, syringes, infusion sets, extension tubing, blood bags, ventilator circuits, stopcocks, seals, and gaskets are typically tested by the extract (elution) method because these products release extractable substances such as plasticizers, antioxidants, curing agents, and residual monomers. Extraction is normally performed at a standard surface-area-to-volume ratio, commonly 3 cm²/mL for regular surfaces or 0.2 g/mL for irregularly shaped solids.
Metallic and Ceramic Implant Materials
Orthopedic implants, bone screws, plates, stents, dental implants, and ceramic components are evaluated for the cytotoxic potential of metal ions, corrosion products, surface treatments, passivation residues, and coatings. Direct contact testing is frequently applied to dense, non-diffusible materials, while extraction testing simulates long-term ion release.
Wound Dressings and Absorbent Materials
Gauze, hydrocolloids, hydrogels, alginates, foams, hemostatic agents, and absorbable hemostatic fabrics are prepared using mass-based extraction ratios and physiological extraction vehicles. Absorbent materials may require adjusted extraction ratios to avoid nutrient depletion artifacts in the culture system.
Dental Materials and Ophthalmic Products
Resin composites, glass ionomer cements, bonding agents, impression materials, denture base resins, and contact lenses are common test articles. Materials that polymerize in situ require complete curing before extraction to avoid false-positive results from residual reactive monomers.
Ancillary and Process Materials
Coatings, adhesives, printing inks, labels, primary packaging films, sterilant residues, cleaning agent residues, and manufacturing lubricants are also assessed, since process-related residues are a frequent root cause of cytotoxic failures in finished devices.
Testing Items
A complete cytotoxicity grading assessment typically encompasses the following testing items, selected according to material characteristics and the chosen method in ISO 10993-5.
- Qualitative morphological cytotoxicity grading on the 0–4 reactivity scale, with microscopic observation of the cell monolayer at 24 h, 48 h, and 72 h
- Quantitative determination of cell viability relative to blank controls using MTT, XTT, WST-1, or neutral red uptake (NRU) bioassays
- Calculation of growth inhibition rate for treated cultures versus control cultures
- Lysis index and zone-of-inhibition measurement for agar diffusion and filter diffusion methods
- Extract characterization, including visual appearance, pH shift, and osmolality, to identify non-specific interference
- Simultaneous evaluation of negative control material (e.g., high-density polyethylene reference material), positive control (e.g., zinc dibutyldithiocarbamate or a detergent-based cytotoxin), and blank extraction medium controls
The qualitative grading scale defined in ISO 10993-5 is applied as follows.
- Grade 0 (None): No observable cytotoxicity; discrete intracytoplasmic granules may be present; no cell lysis and no reduction of cell growth
- Grade 1 (Slight): Not more than 20% of cells are rounded, loosely attached, or morphologically altered; occasional lysed cells; only slight growth inhibition
- Grade 2 (Mild): Not more than 50% of cells are rounded or devoid of intracytoplasmic granules; no extensive cell lysis; growth inhibition not exceeding 50%
- Grade 3 (Moderate): Not more than 70% of cells are rounded, lysed, or detached; growth inhibition not exceeding 70%
- Grade 4 (Severe): Nearly complete destruction of the cell layer
Testing Methods
Sample Extraction and Preparation
Extraction is performed in compliance with ISO 10993-12 using vehicles compatible with the cell culture system, most commonly serum-supplemented minimal essential medium (MEM) or Dulbecco's modified Eagle medium (DMEM). When a second vehicle is required for chemical characterization, physiological saline or water for injection is used. Standard extraction conditions include 37°C for 24 h, 37°C for 72 h, 50°C for 72 h, 70°C for 24 h, or 121°C for 1 h; the condition selected should simulate or exaggerate clinical use without degrading the material in an unrealistic manner. Extraction is conducted under aseptic conditions, and extracts are applied to cultures promptly to avoid degradation.
Extract (Elution) Test
The extract test is the most versatile and most frequently used method. Extracts at 100% concentration (and, for quantitative work, serial dilutions) are applied to confluent L929 monolayers, and cultures are incubated at 37°C in a humidified 5% carbon dioxide atmosphere. Cultures are examined microscopically at 24 h, 48 h, and 72 h, and cytotoxicity is graded from 0 to 4 based on morphology, lysis, and growth inhibition observed in at least triplicate cultures.
Direct Contact Test
In the direct contact method, a sterile sample piece is placed onto or adjacent to the cell monolayer and incubated, typically for 24 h. Cytotoxicity arises either from direct mechanical or chemical interaction with the cells or from leachable substances at the interface. The method is suited to low-density materials such as films and elastomers where leachables can diffuse into the medium, and it provides the most realistic simulation of direct tissue contact.
Indirect Contact Tests: Agar Diffusion and Filter Diffusion
In the agar diffusion (agar overlay) test, cells are covered with a thin layer of nutrient agar before the sample is placed on the agar surface; toxic leachables must diffuse through the agar to reach the cells, and results are reported using both a zone index and a lysis index. In the filter diffusion test, cells are grown on a cellulose acetate membrane and exposed to the sample from the opposite side. Both methods are appropriate for high-density materials such as rubbers and molded plastics where the extract method may understate surface-mediated effects.
Quantitative Viability Assays
Quantitative approaches, led by the MTT assay, measure the metabolic conversion of a tetrazolium salt to formazan by viable cells, with absorbance read spectrophotometrically. Per ISO 10993-5:2009, a test article is considered non-cytotoxic when cell viability is greater than 70% of the blank control. Dilution series testing additionally establishes a dose–response relationship and identifies the concentration at which cytotoxicity begins, which is valuable for root-cause analysis and material optimization.
Grading Criteria and Acceptance
A cytotoxicity grading assessment is judged acceptable when the negative control produces a grade of 0 and the positive control produces a grade of 2 to 4, confirming test system sensitivity. Under ISO 10993-5, test articles producing cytotoxicity greater than grade 2 are considered to have failed. In routine regulatory practice, grades of 0 or 1 are accepted without further justification, while grades of 2 or higher trigger engineering review, chemical characterization under ISO 10993-18, or material replacement. For quantitative data, the 70% viability threshold is the decisive criterion.
Applications
Cytotoxicity grading data generated by accredited third-party laboratories or in-house ISO/IEC 17025-accredited facilities is used across the entire device lifecycle.
- Regulatory registration submissions in major jurisdictions, including China NMPA registration using GB/T 16886.5, United States FDA 510(k) and PMA submissions, and CE technical documentation under the EU Medical Device Regulation, where ISO 10993-5 data anchors the biological evaluation file
- Research and development screening of candidate polymers, additives, coatings, and sterilization-compatible formulations before tooling investment
- Change control evaluation when suppliers, resin grades, cure cycles, adhesives, or sterilization methods are modified
- Verification of cleaning and sterilization processes for residual detergent, ethylene oxide, or gamma-irradiation byproducts
- Periodic batch release testing for high-risk product families and supplier qualification audits
- Compilation of the biological evaluation report required by ISO 10993-1 as part of risk management documentation
FAQ
What cytotoxicity grade is required to pass the test?
Grades 0 and 1 are universally accepted as non-cytotoxic. ISO 10993-5 treats results greater than grade 2 as a failure, and grades 2 to 4 require justification, chemical characterization, or design intervention. For quantitative methods, cell viability above 70% of the blank control constitutes a pass.
Which cell line is most commonly used?
The L929 mouse connective tissue fibroblast line is the reference cell line recommended in ISO 10993-5 Annex A and is used by the majority of laboratories worldwide. V79 Chinese hamster lung fibroblasts and BALB/c 3T3 cells are acceptable alternatives, provided sensitivity is demonstrated with positive controls.
How long does a cytotoxicity grading assessment take?
After sample receipt and extraction, the test itself typically takes 3 to 5 working days, including 24 h, 48 h, and 72 h observation points. Including extraction, cell culture preparation, controls, and report issuance, most projects are completed within 2 to 3 weeks.
Which extraction condition should be selected?
The extraction condition should reflect clinical exposure while ensuring adequate extraction efficiency. The common defaults are 37°C for 24 hours for devices with limited clinical contact time, and 37°C for 72 hours, 50°C for 72 hours, or 70°C for 24 hours for prolonged or permanent-contact devices. Justification for the selected condition must be documented in the test report.
What is the difference between qualitative and quantitative cytotoxicity testing?
Qualitative testing assigns a 0–4 morphological grade based on microscopic observation and is well suited to standard screening. Quantitative testing measures cell viability or growth inhibition numerically, providing dose–response information and a clear 70% viability decision threshold. Many regulatory submissions now include both data sets, and quantitative endpoints are increasingly preferred for high-risk devices.
What should be done if a sample fails the cytotoxicity test?
A failing grade should prompt a structured investigation: verify extraction and handling conditions, perform extractable and leachable studies under ISO 10993-18 to identify the causative substance, and evaluate process changes such as extended post-curing, alternative materials, or modified sterilization. Retesting on a revised formulation without root-cause analysis rarely resolves the underlying biological risk.